TUG1 and hepatocellular carcinoma: Based on these results, we conclude that TUG1 can be used as a ceRNA to competitively bind miR-29a to promote the expression of IFITM3, which in turn affects the invasion, metastasis, proliferation, and apoptosis of HCC.